Resultados da busca - Johannes Holtschmidt

  • Mostrando 1 - 4 resultados de 4
Refinar Resultados
  1. 1
    Surgical treatment of primary breast cancer in the neoadjuvant setting

    Surgical treatment of primary breast cancer in the neoadjuvant setting por Sherko Kümmel, Johannes Holtschmidt, Sibylle Loibl

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    310P Quality of life with first-line ET + palbociclib vs standard mono-chemotherapy in high risk HER2-/HR+ mBC and indication for chemotherapy in the PADMA study

    310P Quality of life with first-line ET + palbociclib vs standard mono-chemotherapy in high risk HER2-/HR+ mBC and indication for chemotherapy in the PADMA study por Vesna Bjelic‐Radisic, Maike Schmidt, M. Thill, Julia Rey, Beate Rautenberg, T. Decker, Joachim Rom, M. Koegel, Kristina Lübbe, Axel Nacke, Sabine Seiler, M. Just, Volkmar Mueller, R. Buss-Steidle, J. Terhaag, Christoph Mundhenke, C. Denkert, Johannes Holtschmidt, S. Loibl

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/<i>ERBB2</i>-Positive Early Breast Cancer

    Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/<i>ERBB2</i>-Positive Early Breast Cancer por Oleg Gluz, Ulrike Nitz, Matthias Christgen, Sherko Küemmel, Johannes Holtschmidt, Johannes Schumacher, Andreas Hartkopf, Jochem Potenberg, Kerstin Luedtke‐Heckenkamp, Marianne Just, Christian Schem, Raquel von Schumann, Cornelia Kolberg‐Liedtke, Christine zu Eulenburg, Timo Schinköthe, Monika Graeser, Rachel Wuerstlein, Ronald Kates, Hans Kreipe, Nadia Harbeck

    Publicado em 2023
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping

    Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping por Carsten Denkert, Sivaramakrishna Rachakonda, Thomas Karn, Karsten E. Weber, Miguel Martín, Frederik Marmé, M. Untch, Hervé Bonnefoi, Sungbae Kim, Sabine Seiler, Harry D. Bear, Agnieszka K. Witkiewicz, Seock Ah Im, Angela DeMichele, Anika Pehl, Laura van’t Veer, Nicole McCarthy, Thorsten Stiewe, Paul Jank, Karen A. Gelmon, José A. García-Sáenz, Christina C. Westhoff, Catherine M. Kelly, Toralf Reimer, Bärbel Felder, Mireia Melé, Erik S. Knudsen, Nicholas Turner, Federico Rojo, Wolfgang Schmitt, Peter A. Fasching, Julia Teply‐Szymanski, Zhe Zhang, Masakazu Toi, Hope S. Rugo, Michael Gnant, Andreas Makris, Johannes Holtschmidt, Valentina Nekljudova, S. Loibl

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: